Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment
Background: The use of remdesivir in patients with coronavirus disease 2019 (COVID-19) and severe renal impairment has been approved; however, limited clinical data exist. Accordingly, we aimed to compare outcomes and adverse events associated with remdesivir in hospitalized patients with COVID-19,...
Saved in:
Main Authors: | Min-Chi Chang (Author), Ping-Feng Wu (Author), Yu-Chien Ho (Author), Wen-Ying Lin (Author), Chia-Ying Wu (Author), Szu-Yu Liu (Author), Chia-Jen Liu (Author), Yi-Tsung Lin (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of Thromboembolism in Non-Valvular Atrial Fibrillation With or Without Clinical Hyperthyroidism
by: Yu-Sheng Lin, et al.
Published: (2021) -
Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys
by: Lin Xu, et al.
Published: (2021) -
Uterine Anomalies with Ipsilateral Renal Agenesis
by: Chi-Feng Su, et al.
Published: (2005) -
Corrective osteotomy with retrograde fassier-duval nail for osteogenesis imperfect patient with bilateral genu valgum
by: Tsung-Yu Lin, et al.
Published: (2017) -
Sex difference in the associations among obesity-related indices with incidence of diabetes mellitus in a large Taiwanese population follow-up study
by: Tung-Ling Chung, et al.
Published: (2023)